OVERVIEW

The USC Peter A. Singer Thyroid Symposium returns for 2024, continuing our dedication to providing a comprehensive and current update in the management of thyroid disease. This will again be a hybrid program, offering options for in-person or virtual attendance. Clinical care of patients with thyroid disorders continues to change and develop in complexity. 
In our 2024 edition, the following is highlighted: disparities in thyroid cancer care along with key areas for specialists and general providers alike: treatment of Graves' disease, additional use of T3 medication, health practices for Hashimoto's disease, evaluation of thyroid nodules, disparities in thyroid cancer care, active surveillance of thyroid cancer and management of lymph node recurrences, and thyroid disease in pregnancy. 
Forward-looking perspectives are presented on the most current state of thyroid medicine informed by evidenced-based management strategies, with sessions combining clinical experience, challenging cases, panel discussions, and audience questions to inform solutions to complex clinical scenarios. 

TARGET AUDIENCE

This course is intended for endocrinologists, primary care providers, nurses and other allied health professionals. Head and Neck or Endocrine surgeons, and trainees seeking to enhance their understanding of thyroid diseases and treatment options in order to select optimal management for their patients. 

LEARNING OBJECTIVES

By the end of the course, participants will be able to:

• Provide optimal patient counselling and consideration for active surveillance for low-risk papillary thyroid cancer.
• Examine new evidence of T4 and T3 combination therapy for hypothyroidism and in what patients it might be used.
• Distinguish advantages and disadvantages between primary treatments for Graves' Disease.
• Recognize areas of healthcare disparity in thyroid cancer care.
• Assess effectiveness of non-pharmaceutical and lifestyle measures of Hashimoto thyroiditis.
• Decide optimal timing and interventions for thyroid cancer lymph node metastases.
• Identify ultrasound findings that impact cancer risk for indeterminate thyroid nodules.
• Review current practice considerations for management of thyroid disease as it pertains to fertility. 

ACCREDITATION

The Keck School of Medicine of the University of Southern California designates this Live Activity activity for a maximum of 4.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.